Ocular Autoimmune Systemic Inflammatory Infectious Study – Report 3: Posterior and Panuveitis

References

• Durrani O, Meads C, Murray P. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223–236.
   PubMed Web of Science ®Google Scholar
• Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103:234–235.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
   PubMed Web of Science ®Google Scholar
• Fernandez DG, Nascimento H, Nascimento C, Muccioli C, Belfort R. Uveitis in São Paulo, Brazil: 1053 New Patients in 15 Months. Ocul Immunol Inflamm. 2017;25(3):382–387.
   PubMed Web of Science ®Google Scholar
• Liberman P, Gauro F, Berger O, Urzua CA. Causes of uveitis in a tertiary center in Chile: a cross-sectional retrospective review. Ocul Immunol Inflamm. 2014;23(4):339–345.
   PubMed Web of Science ®Google Scholar
• Bajwa A, Osmanzada D, Osmanzada S; et al. Epidemiology of uveitis in the mid-Atlantic United States. Clin Ophthalmol. 2015;9:889–901.
   PubMed Web of Science ®Google Scholar
• Gritz D, Wong IG. Incidence and prevalence of uveitis in Northern California: the Northern California epidemiology of uveitis study. Ophthalmology. 2004;111(3):491–500.
   PubMed Web of Science ®Google Scholar
• Win MZA, Win T, Myint S, Shwe T, Sandar H. Epidemiology of uveitis in a tertiary eye center in Myanmar. Ocul Immunol Inflamm. March, 2016;1–6.
   PubMed Web of Science ®Google Scholar
• Silpa-Archa S, Noonpradej S, Amphornphruet A. Pattern of uveitis in a referral ophthalmology center in the central district of Thailand. Ocul Immunol Inflamm. 2014;23(4):320–328.
   PubMed Web of Science ®Google Scholar
• Ohguro N, Sonoda K-H, Takeuchi M, Matsumura M, Mochizuki M. The2009 prospective multi-center epidemiologic survey of uveitis in Japan. Jpn J Ophthalmol. 2012;56(5):432–435.
   PubMed Web of Science ®Google Scholar
• Gao F, Zhao C, Cheng G; et al. Clinical Patterns of Uveitis in a Tertiary Center in North China. Ocul Immunol Inflamm. April, 2016;1–7.
   Web of Science ®Google Scholar
• Dhibi HAA, Shamsi HNA, Al-Mahmood AM; et al. Patterns of Uveitis in a Tertiary Care Referral Institute in Saudi Arabia. Ocul Immunol Inflamm. 2017;25(3):388–395.
   PubMed Web of Science ®Google Scholar
• Al-Shakarchi F. Pattern of uveitis at a referral center in Iraq. Middle East Afr J Ophthalmol. 2014;21(4):291–295.
   PubMedGoogle Scholar
• Jones NP. The manchester uveitis clinic: the First 3000 patients—epidemiology and casemix. Ocul Immunol Inflamm. 2013;23(2):118–126.
   PubMed Web of Science ®Google Scholar
• Jones NP. The Manchester uveitis clinic: the first 3000 patients, 2: uveitis manifestations, complications, medical and surgical management. Ocul Immunol Inflamm. 2014;23(2):127–134.
   PubMed Web of Science ®Google Scholar
• Llorenç V, Mesquida M, Maza MSDL; et al. Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization. Acta Ophthalmol. 2015;93(6):561–567.
   PubMed Web of Science ®Google Scholar
• Grajewski RS, Caramoy A, Frank KF; et al. Spectrum of uveitis in a German tertiary center: review of 474 consecutive patients. Ocul Immunol Inflamm. 2015;23(4):346–352.
   PubMed Web of Science ®Google Scholar
• Khairallah M, Yahia SB, Ladjimi A; et al. Pattern of uveitis in a referral centre in Tunisia, North Africa. Eye (Lond). 2007;21(1):33–39.
   PubMed Web of Science ®Google Scholar
• Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994;117(5):663–666.
   PubMed Web of Science ®Google Scholar
• Newman H, Gooding C. Viral ocular manifestations: a broad overview. Rev Med Virol. 2013;23(5):281–294.
   PubMed Web of Science ®Google Scholar
• Gupta V, Gupta A, Rao NA. Intraocular tuberculosis—an update. Surv Ophthalmol. 2007;52(6):561–587.
   PubMed Web of Science ®Google Scholar
• Vasconcelos-Santos DV, Zierhut M, Rao NA. Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm. 2009;17(5):351–355.
   PubMed Web of Science ®Google Scholar
• International Team for the Revision of the International Criteria for Behçet’s Disease. (ITR-ICBDTInternational Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2013;28(3):338–347.
   PubMed Web of Science ®Google Scholar
• Read RW, Holland GN, Rao NA; et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652.
   PubMed Web of Science ®Google Scholar
• World Health Organisation. H54: visual impairment including blindness (binocular or monocular). ICD-10 Version:2015. http://apps.who.int/classifications/icd10/browse/2015/en#/h54. Accessed September 25, 2016.
   Google Scholar
• Wakefield D, Chang JH. Epidemiology of Uveitis. Int Ophthalmol Clin. 2005;45(2):1–13.
   PubMedGoogle Scholar
• Wittenborn JS, Zhang X, Feagan CW; et al. The Economic burden of vision loss and eye disorders among the united states population younger than 40 years. Ophthalmology. 2013;120(9):1728–1735.
   PubMed Web of Science ®Google Scholar
• Ler TS, Ang LW, Yap GSL; et al. Epidemiological characteristics of the 2005 and 2007 dengue epidemics in Singapore - similarities and differences. Western Pac Surveill Response J. 2011;2(2):24–29.
   PubMedGoogle Scholar
• Chee E, Sims JL, Jap A, Tan BH, Oh H, Chee S-P. Comparison of prevalence of dengue maculopathy during two epidemics with differing predominant serotypes. Am J Ophthalmol. 2009;148(6):910–913.
   PubMed Web of Science ®Google Scholar
• Kijlstra A, Petersen E. Epidemiology, Pathophysiology, and the Future of Ocular Toxoplasmosis. Ocul Immunol Inflamm. 2014;22(2):138–147.
   PubMed Web of Science ®Google Scholar
• Demar M, Ajzenberg D, Maubon D; et al. Fatal outbreak of human toxoplasmosis along the Maroni River: epidemiological, clinical, and parasitological aspects. Clin Infect Dis. 2007;45(7):e88–E95.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal infection? Br J Ophthalmol. 2000;84(2):224–226.
   PubMed Web of Science ®Google Scholar
• Wong A, Tan KH, Tee CS, Yeo GS. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med J. 2000;41(4):151–155.
   PubMedGoogle Scholar
• Fonseca AL, Silva RA, Fux B, Madureira AP, Sousa FFD, Margonari C. Epidemiologic aspects of toxoplasmosis and evaluation of its seroprevalence in pregnant women. Rev Soc Bras Med Trop. 2012;45(3):357–364.
   PubMed Web of Science ®Google Scholar
• Cook AJ, Gilbert RE, Buffolano W; et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. Br Med J. 2000;321(7254):142–147.
   PubMed Web of Science ®Google Scholar
• Kijlstra A, Jongert E. Control of the risk of human toxoplasmosis transmitted by meat. Int J Parasitol. 2008;38(12):1359–1370.
   PubMed Web of Science ®Google Scholar
• AVA. Legislation. http://www.ava.gov.sg/e-services/legislation. Last accessed July 30, 2016.
   Google Scholar
• Jabs DA, Ahuja A, Natta MLV, Lyon AT, Yeh S, Danis R. Long-term outcomes of cytomegalovirus retinitis in the era of modern antiretroviral therapy. Ophthalmology. 2015;122(7):1452–1463.
   PubMed Web of Science ®Google Scholar
• Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL. Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2012;153(6):1016–1024.
   PubMed Web of Science ®Google Scholar
• Şengün A, Karadağ R, Karakurt A, Sarıcaoğlu MS, Abdik O, Hasıripi H. Causes of uveitis in a referral hospital in Ankara, Turkey. Ocul Immunol Inflamm. 2005;13(1):45–50.
   PubMed Web of Science ®Google Scholar
• Tomkins-Netzer O, Talat L, Bar A; et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121(12):2387–2392.
   PubMed Web of Science ®Google Scholar
• Tomkins-Netzer O, Lightman S, Drye L; et al. Outcome of treatment of uveitic macular edema: the multicenter uveitis steroid treatment trial 2-year results. Ophthalmology. 2015;122(11):2351–2359.
   PubMed Web of Science ®Google Scholar
• Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A. Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm. 2009;17(4):243–248.
   PubMed Web of Science ®Google Scholar
• Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma. 2004;13(6):461–465.
   PubMed Web of Science ®Google Scholar
• The Multicenter Uveitis Steroid Treatment Trial Research Group. The Multicenter Uveitis Steroid Treatment (MUST) Trial: rationale, design and baseline characteristics. Am J Ophthalmol. 2010;149(4):550–561.
   PubMed Web of Science ®Google Scholar
• Nicholson BP, Zhou M, Rostamizadeh M; et al. Epidemiology of epiretinal membrane in a large cohort of patients with uveitis. Ophthalmology. 2014;121(12):2393–2398.
   PubMed Web of Science ®Google Scholar
• Markomichelakis NN, Halkiadakis I, Pantelia E; et al. Course of macular edema in uveitis under medical treatment. Ocul Immunol Inflamm. 2007;15(2):71–79.
   PubMed Web of Science ®Google Scholar
• Chen EJ, Bin Ismail MA, Mi H, et al. Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) - Report 1: epidemiology and Classification. Ocul Immunol Inflamm. Dec, 5 2016;1–15. 10.1080/09273948.2016.1249376. [Epub ahead of print]
   Web of Science ®Google Scholar